Abstract Objectives: To assess outcomes (wound healing, amputation and mortality) after vacuum assisted closure (VAC â ) therapy of peri-vascular surgical site infections in the groin after arterial surgery. Design: Retrospective study. â therapy was applied in the groin at a continuous topical negative pressure of 125 mm Hg. The median follow up time was 16 months. Results: Median age was 75 years. Twenty-three (70%) cases underwent surgery for lower limb ischaemia. Intestinal flora was present in 88% of the wound cultures. Median duration of VAC â therapy was 20 days and 27 (82%) wounds healed within 55 days. One serious VAC â associated bleeding and three late false femoral artery aneurysms were reported. The median cost of VAC â treatment was 2.7% of the in-hospital costs. Synthetic vascular graft infection (n Z 21) was associated with adverse infection-related events (n Z 9; p Z 0.012). Non-healing wounds were associated with amputation (p Z 0.005) and death (p < 0.001). Conclusions: VAC â treated synthetic vascular graft infections in the groin were at a greater risk of developing infection-related complications. Non-healing surgical site infections after VAC â therapy were associated with amputation and death. ª
Introduction
Although a relatively new technique, the application of vacuum assisted wound closure (VAC â ) has expanded and the annual number of publications on VAC â has increased rapidly. The experimental 1 and clinical 2 data that were launched in 1997 have been a major breakthrough in the wound care area. The current indications for VAC â , according to the manufacturer KCI Medical, are: Chronic open wounds such as diabetic foot ulcer and pressure ulcers, acute and traumatic wounds, healing of skin grafts and open abdomen. 3, 4 Surgical incision in the groin and exposure of the common femoral artery is one of the most common procedures in vascular surgery. Unfortunately, the skin in the groin is a major reservoir of bacteria and surgical site infections are common. 5 Deep peri-vascular postoperative wound infection in the groin after arterial surgery is sometimes related to death and/or limb loss. Apart from great patient discomfort, in-hospital stay tends to be long and complicated, associated with substantial costs. The incidence of early wound infection including lymph fistula after arterial surgery was reported to be 6.4% of 873 groins, 6 whereas major groin complications, either formation of false femoral artery aneurysms or infection, after reconstructions with synthetic graft material were reported to be 5% 7 during a median follow up time of 60 months. Patients with infection of an exposed synthetic graft in the groin often have been treated by excision of the graft or part of the graft, with or without revascularisation with an extra-anatomic by-pass or in situ vein-by-pass, with subsequent high risk of both leg amputation and death. 8 Exposed and infected grafts are sometimes treated with muscle flap coverage and antibiotics in an attempt to try to preserve the vascular reconstruction, but the reinfection rate has been reported to be as high as 35%. 9 
VAC
â therapy of infected grafts in the groin only has been described in small series but with promising results in terms of wound healing, graft preservation and lack of complications. 10e12 The aim of the present study was to assess wound healing, amputation and mortality after VAC â therapy of peri-vascular surgical site infections in the groin in a larger patient cohort.
Material and Methods

Study population and setting
The Vascular Centre, Malmö-Lund, Malmö University Hospital, is a tertiary referral centre for the southernmost part of Sweden with a primary catchment population of approximately 756 000 inhabitants (Swedish Central Bureau of Statistics, www.scb.se). A prospective wound surveillance registry within the department was started in March 2005 to document occurrences of post-operative surgical site infections. Development of infections outside hospital are detected either at stitch removal and then reported by district nurses, or at the follow up visit, or in a registry that links the operation planning programme with the wound culture register at the Department of Microbiology. Patients undergoing groin incisions for any vascular procedure were given routinely three prophylactic doses of the antibiotic dicloxacillin (Ekvacillin â ), where the first dose was administered at induction of anaesthesia. Cross checking for VAC â treated patients was performed through the wound surveillance register and the lists of invoices from the manufacturer of the VAC â system (KCI Medical). A retrospective study of patient records from 1st of August 2004 until 31st of December 2006 of all patients receiving VAC â therapy for peri-vascular groin infections after vascular surgery was performed. Costs for VAC â therapy and overall inhospital costs were estimated.
Treatment policy of VAC â therapy
Patients with deep groin infections underwent surgery for wound revision with either regional or general aaesthesia. Wound cultures adjacent to the graft or native arteries were obtained. VAC â therapy was started the day after the revision and a polyurethane sponge (KCI Medical, San Antonio, Texas, USA) was applied with a continuous topical negative pressure of 125 mm Hg. Changes of dressings were performed three times per week. Visible graft material and native arteries were covered routinely with a nonadhesive silicon-based dressing (Mepitel â , Mölnlycke Health Care AB, Göteborg, Sweden) to minimize any possible trauma to the vascular anastomosis or arterial reconstruction, which hypothetically could be generated by the VAC â therapy. The patients were treated in-hospital as long as any graft material or native artery was visible. As soon as the arterial reconstruction was covered with granulation tissue, in an otherwise fit patient, continued VAC â therapy at home, with the mini-VAC â portable device (VAC â Freedom), was considered. The wound was followed until full skin epithelialisation. Local complications were documented from start of VAC â therapy to the end of study. Two patients with concomitant VAC â therapy to the groin and an open abdomen were excluded from this study due to severity of abdominal disease and excess risk of mortality.
Statistical methods
Data management and statistical analysis were performed using the SPSS for Windows, version 14.0 (SPSS Inc., Chicago, Illnois, USA). Differences in proportions were analysed with the chi-square test or Fisheŕs exact test. Continuous variables were expressed in median and range. The costs in Swedish crowns (SEK) were transferred into the Euro currency (exchange rates from 28th of August; www.forex.se). P-values < 0.05 were considered significant.
Results
Patients
The median age of the 28 patients was 75 years (range 48e 88 years). Almost half, 14/23 (42%) of the infected groins were in patients with diabetes mellitus. Primary indications for vascular intervention were critical lower limb ischaemia (n Z 23), abdominal aortic aneurysm (n Z 7) and coronary insufficiency (n Z 3). The following procedures were followed by peri-vascular groin infection: Thrombendarterectomy of the common femoral artery (n Z 8) and/or profunda femoris artery (n Z 2), femoral e femoral crossover (n Z 3), replacement of the common femoral artery by a interposition bypass graft (n Z 3), femoral embolectomy (n Z 3), femoro-popliteal bypass (n Z 3), percutaneous coronary intervention (n Z 3), endovascular repair of VAC â Therapy of Peri-vascular Infections in the Groinabdominal aortic aneurysm (EVAR) (n Z 7) and aortobifemoral by-pass graft (n Z 1). Among the 21 patients where synthetic graft material was inserted in the femoral artery, nine had polytetraflouro ethylene (PTFE, Gore-Tex â ) bypass grafts and 12 had Dacron (Vascutek â ) patches. Median hospital stay was 23 days (range 3e82).
Microbiology
Bacteria pertaining to the intestinal flora were present in the majority, 88% (29/33) of the wounds in the groin ( Table 1 ). The most common single bacteria was Enterococcus faecalis, which was isolated in 12 (36%) groins. Staphylococcus aureus was present in five groins (15%). In view of the results of the final bacterial resistance pattern, the initial antibiotic therapy was inadequate in 18 (55%) cases.
VAC
â therapy VAC â therapy was applied to 33 infected groins (Table 2) , of whom 21 (64%) were men. Exposed and infected synthetic and vein grafts were present in 21 (64%) and three (9%) groins, respectively. Twenty-seven (82%) infected groins healed (Table 3) . Among the six (18%) unhealed wounds, four patients died as a consequence of infection. Concomitant VAC â therapy of non-inguinal wounds was applied in five patients: after fasciotomies in the lower leg (n Z 1), infected synthetic graft in the upper leg (n Z 1), infected vein graft in the lower leg (n Z 1), infected synthetic graft in the abdominal wall (n Z 1) and a non-surgical site foot ulcer (n Z 1).
Costs
The median in-hospital cost for the patients was 26,022 Euros (4078e136 330). The median total cost per patient for the VAC â treatment, including the out patient treatments, was 1,299 Euros (210e7416). The cost of VAC â treatment in relation to the in-hospital cost in those 15 patients that completed the VAC â therapy in-hospital was 2.7% (range 0.6e9.9%).
VAC
â associated bleeding VAC â associated bleeding occurred in two hospital patients: One patient underwent emergency surgery for a synthetic graft infection in the groin and intermittent bleeding from a false femoral artery aneurysm, and the synthetic patch was replaced by a vein patch. Due to persistent infection, revision of the wound was made, followed by VAC â therapy, 10 days later. Four days after commencing the VAC â therapy, the patient experienced a severe bleeding episode from the groin with circulatory instability. There was a rapid swelling of the left groin and the vacuum system was occluded after collecting 1 litre of blood in the canister. An emergency operation revealed a disruption of the necrotic and infected vein patch. The vein patch was replaced by a vein interposition graft, harvested from the superficial femoral vein, and coverage was performed with a sartorius muscle flap. The patient recovered well.
The second patient initially had undergone direct suture of the common femoral artery, because of false femoral artery aneurysm after an EVAR procedure, followed by a sartorius muscle flap. VAC â therapy followed and 14 days later moderate arterial bleeding from the wound occurred and the VAC â system was occluded due to aggregation of coagulated blood in the groin. The exact source of this arterial bleeding was not identified. VAC â therapy was discontinued and it was decided to seal the common femoral artery, the following day, by coiling the superficial femoral 
Intestinal flora
Enterococcus faecalis 12 Pseudomonnas aeruginosa 7 Enterococcus faecium 6 Proteus mirabilis 4 Eschericia coli 3 Enterobacter cloacae 3 Enterococcus species 2 Klebsiella oxytoca 2 Proteus vulgaris 1 Klebsiella pneumoniae 1 Citrobacter freundii 1 Moraxella Catarrhalis 1 Clostridium Ramosum 1 Bacteroides Fragilis 1 Anaerobic bakteriae 10 Enterococcus 7 Faecal flora 6
Mixture of flora 3
Sum 97 artery and deploy a stentgraft from the profunda femoral artery to the external iliac artery through vascular access from right brachial artery. VAC â therapy was restarted on the first postoperative day and the wound healed.
Infection-related local complications after VAC â therapy Four patients experienced late infection-related complications. One patient was bleeding intermittently from an infected false femoral artery aneurysm one month after completion of VAC â therapy. The wound was not completely healed and at emergency operation the synthetic graft was observed to be partially disconnected from the arterial wall. The graft material was removed and the artery was repaired with an arterial patch. The wound healed without further VAC â therapy and the follow-up was uneventful.
The second patient was admitted with acute bleeding from the groin due to a false femoral artery aneurysm 6 months after complete wound healing of an infected femoral-femoral bypass graft. All visible synthetic graft material in the groin was removed during an emergency operation, and in a second operation, an above-knee amputation for severe ischaemia of the leg was performed.
The third patient had a false femoral artery aneurysm, without any bleeding episodes, 3 months after completion of wound healing. The synthetic patch in the common femoral artery was removed and the external iliac and profunda femoral arteries were ligated, followed by a femoral-popliteal crossover bypass with synthetic material. However, at a second operation, a below-knee amputation was necessary due to occlusion of the bypass, and at a third operation, removal of the infected bypass was necessary.
The fourth patient developed a superficial wound infection, emanating from the wound scar in the groin, 6 months after completion of wound healing. The patient recovered well after antibiotic therapy.
In total, synthetic grafts were removed in 3 cases and vein graft in one case. The removal rate of grafts was 4/24 (17%).
Amputation and mortality
The median follow up time was 16 months. Six (18%) patients were amputated (Table 3) , three amputations were during the same hospitalisation period as the VAC â treatment. The level of amputation was ex-articulation of the hip joint (n Z 1), above-knee (n Z 3) and below-knee (n Z 2). There was a lower healing rate following synthetic graft infection (n Z 21), but this was only of borderline significance (p Z 0.06). There was a borderline higher amputation rate associated with synthetic grafts (p Z 0.06), but mortality among those with synthetic grafts was not increased (p Z 0.43). When summarizing the infectionrelated events, synthetic graft infection was found to be associated with adverse outcome in a total of nine (43%) groins (p Z 0.012), in terms of no wound healing (n Z 6), formation of false femoral artery aneurysm (n Z 3), superficial wound infection (n Z 1) and amputation (n Z 6). The wounds in all 12 patients without synthetic graft infection healed uneventfully. Non-healing wounds in the groin were associated with amputation (p Z 0.005) and death (p < 0.001; Table 3 ). Amputation was associated with death (p Z 0.034). The amputation-free survival rate during follow-up was 67% (22/33).
Discussion
The wound healing rate of the VAC â treated peri-vascular surgical site infections in the groin was high, 82%, despite VAC â Therapy of Peri-vascular Infections in the Groina high proportion of patients with diabetes mellitus, critical lower limb ischaemia, synthetic graft infection and inadequate antibiotic therapy. The incidence of synthetic graft infection was 64%, and the occurrence of adverse infection-related events was high, 43%, in this subgroup of 21 patients, whereas no such complications occurred among the 12 patients without synthetic graft infection. Wound healing seems to be crucial in these patients, since a non-healing wound was associated with both amputation and death. The crude 1-year mortality rate in the present study is similar to the reported 1-year mortality rate of 24% in patients with critical limb ischaemia without a concomitant graft infection from the same city. 13 The manufacturers of the VAC â system, KCI Medical, do not recommend VAC â therapy for exposed vessels or vascular reconstructions.
14 In cases of graft infection, graft removal and amputation is an unattractive treatment option. In view of the encouraging reports of VAC â treatment, 15, 16 we have adopted this technique for wound healing in an attempt to preserve the vascular reconstructions. Arterial bleeding during VAC â therapy of these deep groin wounds occurred in two cases, a complication which not has been described in any of the previous series. However, it seems that a few centres, apart from ours, also have experienced VAC â associated serious bleeding complications. 17 The bleeding episodes in the present study were mediated through the polyurethane sponge, which is firmly attached to the wound during suction and has larger pores for greater drainage capability, whereas the polyvinyl alcohol sponges used in the other centre 17 are considered more lenient, with smaller pores and less in-growth characteristics. However, it is very likely that the serious bleeding that occurred during VAC â therapy in our patients, would have occurred spontaneously at a later date, and that the negative suction applied just revealed the non-durable vascular reconstruction at an earlier time point.
The incidence of both superficial and deep surgical site infections in the groin after vascular surgery was high during the study period, which might reflect an efficient wound surveillance register. 18 However, it is likely that there also exist a problem with hygienic patient care. For instance, intestinal flora predominated in the wound cultures, whereas staphylococcus was prevalent in 15% of the groins. Several explanations for the high incidence of intestinal flora are possible: First, dicloxacillin is used as a preventive measure against evolution of staphylococcus infection. Secondly, the groin is considered as an unclean area located adjacent to the uro-anal region. Moreover, non-surgical ulcer infections on the same hospital ward also have been studied during the same period within the wound infection registry, showing a majority of intestinal flora among the wound cultures. 18 Hence cross-contamination of patients awaiting elective surgery at the ward may have occurred, with subsequent development of infection in some. In view of the microbiology results, we have changed our routine for the initial treatment of wound infections in the groin, and replaced dicloxacillin with more broad-spectrum antibiotic therapy, such as piperacillin þ tazobactam (Tazocin â ) or trimetoprim þ sulfametoxazol (Eusaprim â ) until the final wound culture results are obtained.
In cases of deep groin infection, VAC
â therapy alone cannot replace the initial surgical wound debridement and thorough surgical revision is a key promoter in facilitating the wound healing effects of VAC â therapy. 19 The VAC â system seems to be able to rapidly clear the wound of positive cultures. 12 However, infection-related major complications in terms of formation of false femoral artery aneurysm during follow-up occurred in 3 patients in the present study. A previous series of 24 patients with a follow up time of 12 months did not report any late complications. 12 This discrepancy may be explained by differences in patient selection and grading of the depth of infection, even though the authors claim that only patients with Szilagyi grade III infections were enrolled. However, the set up of the vacuum systems were not identical as our patients received treatment through a polyurethane sponge with a continuous negative pressure of 125 mm Hg, whereas the other patient cohort 12 received therapy through a polyvinyl alcohol sponge with much higher negative pressure, fluctuating between 400 and 600 mm Hg. Further research is needed on the relationship between VAC â therapy characteristics and bacterial clearance from synthetic vascular grafts. Until proven otherwise, manifest infection of a synthetic vascular graft should be considered a significant risk factor for the development of false femoral artery aneurysm, 20 even after an apparently successful treatment period with VAC â . The costs for the VAC â treatment in relation to the inhospital care were low. An increased awareness about the possibility of either continuing VAC â therapy outside hospital or performing secondary skin suture in a vertical mattress fashion manner after 14 days of VAC â12 may further reduce the cost. VAC â therapy commonly is reported as a cost-effective treatment, but few studies and no randomized trials can confirm this. There is an analysis of a large retrospective comparative case control series, which favours the VAC â therapy in terms of lower costs due to much faster healing time. 21 Some groin wounds after vascular surgery leak large amount of lymph fluid for several weeks, and the VAC â system provides superior control system of this leakage 11 in comparison to conventional dressings. In such circumstances, conventional dressings are cost-ineffective and hampered by frequent changes of dressings every day, skin irritation of excessive fluid, and frequent changes of patient and bed linen. Moreover, patient care is difficult to manage outside hospital with increased risk of immobilization.
The limitations of the present study are attributed to its retrospective nature and the lack of a comparative group. Therefore a prospective randomized trial has started recently in our unit to evaluate the usefulness of VAC â therapy compared to best alternative conservative treatment, in terms of wound healing, quality of life and cost effectiveness.
VAC â therapy of peri-vascular groin infections may be considered the first choice of therapy leading to a high rate of preservation of vascular graft reconstructions. VAC â treated synthetic vascular graft infections in the groin are at greater risk of developing infection-related complications. Non-healing surgical site infections after VAC â therapy were associated with an increased risk of amputation and death.
